Meanwhile, it is worth noting that GALNT5, which is hardly ever reported in PDAC, is the only member in this family that is highly expressed in pancreatic cancer and has a worse prognosis compared with the low-expression group. This evidence concerns the gene GALNT5 and pancreatic neoplasm.